expert publishing medicine ltd Company Information
Company Number
04059017
Next Accounts
Sep 2025
Industry
Publishing of learned journals
Other publishing activities
Shareholders
informa uk limited
Group Structure
View All
Contact
Registered Address
5 howick place, london, SW1P 1WG
Website
www.futuremedicine.comexpert publishing medicine ltd Estimated Valuation
Pomanda estimates the enterprise value of EXPERT PUBLISHING MEDICINE LTD at £3.3m based on a Turnover of £4.2m and 0.78x industry multiple (adjusted for size and gross margin).
expert publishing medicine ltd Estimated Valuation
Pomanda estimates the enterprise value of EXPERT PUBLISHING MEDICINE LTD at £1.6m based on an EBITDA of £373.3k and a 4.17x industry multiple (adjusted for size and gross margin).
expert publishing medicine ltd Estimated Valuation
Pomanda estimates the enterprise value of EXPERT PUBLISHING MEDICINE LTD at £2m based on Net Assets of £1.1m and 1.88x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Expert Publishing Medicine Ltd Overview
Expert Publishing Medicine Ltd is a live company located in london, SW1P 1WG with a Companies House number of 04059017. It operates in the publishing of learned journals sector, SIC Code 58141. Founded in August 2000, it's largest shareholder is informa uk limited with a 100% stake. Expert Publishing Medicine Ltd is a mature, small sized company, Pomanda has estimated its turnover at £4.2m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Expert Publishing Medicine Ltd Health Check
Pomanda's financial health check has awarded Expert Publishing Medicine Ltd a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
3 Strong
3 Regular
5 Weak
Size
annual sales of £4.2m, make it larger than the average company (£2.6m)
£4.2m - Expert Publishing Medicine Ltd
£2.6m - Industry AVG
Growth
3 year (CAGR) sales growth of -14%, show it is growing at a slower rate (4%)
- Expert Publishing Medicine Ltd
4% - Industry AVG
Production
with a gross margin of 71.7%, this company has a comparable cost of product (60.7%)
71.7% - Expert Publishing Medicine Ltd
60.7% - Industry AVG
Profitability
an operating margin of 8.6% make it as profitable than the average company (9.6%)
8.6% - Expert Publishing Medicine Ltd
9.6% - Industry AVG
Employees
with 44 employees, this is above the industry average (26)
44 - Expert Publishing Medicine Ltd
26 - Industry AVG
Pay Structure
on an average salary of £51.1k, the company has an equivalent pay structure (£57.2k)
£51.1k - Expert Publishing Medicine Ltd
£57.2k - Industry AVG
Efficiency
resulting in sales per employee of £96.4k, this is less efficient (£143.2k)
£96.4k - Expert Publishing Medicine Ltd
£143.2k - Industry AVG
Debtor Days
it gets paid by customers after 81 days, this is later than average (44 days)
81 days - Expert Publishing Medicine Ltd
44 days - Industry AVG
Creditor Days
its suppliers are paid after 76 days, this is slower than average (36 days)
76 days - Expert Publishing Medicine Ltd
36 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Expert Publishing Medicine Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 18 weeks, this is less cash available to meet short term requirements (43 weeks)
18 weeks - Expert Publishing Medicine Ltd
43 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 63.4%, this is a higher level of debt than the average (42.5%)
63.4% - Expert Publishing Medicine Ltd
42.5% - Industry AVG
EXPERT PUBLISHING MEDICINE LTD financials
Expert Publishing Medicine Ltd's latest turnover from December 2023 is £4.2 million and the company has net assets of £1.1 million. According to their latest financial statements, Expert Publishing Medicine Ltd has 44 employees and maintains cash reserves of £653.9 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 4,239,623 | 4,308,622 | |||||||||||||
Other Income Or Grants | 0 | 0 | |||||||||||||
Cost Of Sales | 1,199,553 | 1,121,654 | |||||||||||||
Gross Profit | 3,040,070 | 3,186,968 | |||||||||||||
Admin Expenses | 2,675,462 | 2,975,625 | |||||||||||||
Operating Profit | 364,608 | 211,343 | |||||||||||||
Interest Payable | 0 | 0 | |||||||||||||
Interest Receivable | 698 | 59 | |||||||||||||
Pre-Tax Profit | 365,306 | 211,402 | |||||||||||||
Tax | -91,240 | -40,669 | |||||||||||||
Profit After Tax | 274,066 | 170,733 | |||||||||||||
Dividends Paid | 75,000 | 360,000 | |||||||||||||
Retained Profit | 199,066 | -189,267 | |||||||||||||
Employee Costs | 2,247,425 | 2,306,326 | |||||||||||||
Number Of Employees | 44 | 46 | 46 | 52 | 47 | 38 | 45 | 45 | 48 | ||||||
EBITDA* | 373,326 | 218,852 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 11,024 | 15,326 | 3,604 | 7,868 | 21,567 | 27,684 | 2,954 | 4,440 | 10,565 | 1,818 | 5,948 | 4,997 | 4,099 | 6,491 | 8,765 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 11,024 | 15,326 | 3,604 | 7,868 | 21,567 | 27,684 | 2,954 | 4,440 | 10,565 | 1,818 | 5,948 | 4,997 | 4,099 | 6,491 | 8,765 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 942,421 | 1,239,926 | 1,060,545 | 1,006,693 | 940,681 | 788,055 | 696,876 | 956,972 | 831,736 | 2,429,931 | 1,642,777 | 1,721,675 | 1,394,739 | 563,043 | 409,158 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 1,311,080 | 1,568,730 | 1,427,192 | 1,331,542 | 878,626 | 544,931 | 695,075 | 865,678 | 1,240,039 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 653,874 | 461,936 | 738,356 | 800,286 | 528,680 | 980,545 | 875,732 | 727,608 | 446,243 | 237,577 | 299,123 | 151,688 | 97,620 | 192,149 | 95,537 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 2,907,375 | 3,270,592 | 3,226,093 | 3,138,521 | 2,347,987 | 2,313,531 | 2,267,683 | 2,550,258 | 2,518,018 | 2,667,508 | 1,941,900 | 1,873,363 | 1,492,359 | 755,192 | 504,695 |
total assets | 2,918,399 | 3,285,918 | 3,229,697 | 3,146,389 | 2,369,554 | 2,341,215 | 2,270,637 | 2,554,698 | 2,528,583 | 2,669,326 | 1,947,848 | 1,878,360 | 1,496,458 | 761,683 | 513,460 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 252,803 | 199,478 | 311,727 | 291,856 | 252,716 | 110,018 | 54,372 | 98,526 | 65,024 | 3,628,280 | 3,937,258 | 3,129,074 | 2,614,793 | 1,530,401 | 1,243,602 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 945,142 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 1,559,376 | 2,215,357 | 1,858,838 | 1,987,486 | 1,720,580 | 1,336,095 | 3,025,125 | 3,826,271 | 4,464,093 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 1,812,179 | 2,414,835 | 2,170,565 | 2,279,342 | 1,973,296 | 2,391,255 | 3,079,497 | 3,924,797 | 4,529,117 | 3,628,280 | 3,937,258 | 3,129,074 | 2,614,793 | 1,530,401 | 1,243,602 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,013,135 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 37,339 | 1,268 | 50 | 701 | 3,146 | 4,149 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 37,339 | 1,268 | 50 | 701 | 3,146 | 4,149 | 0 | 0 | 0 | 1,013,135 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 1,849,518 | 2,416,103 | 2,170,615 | 2,280,043 | 1,976,442 | 2,395,404 | 3,079,497 | 3,924,797 | 4,529,117 | 4,641,415 | 3,937,258 | 3,129,074 | 2,614,793 | 1,530,401 | 1,243,602 |
net assets | 1,068,881 | 869,815 | 1,059,082 | 866,346 | 393,112 | -54,189 | -808,860 | -1,370,099 | -2,000,534 | -1,972,089 | -1,989,410 | -1,250,714 | -1,118,335 | -768,718 | -730,142 |
total shareholders funds | 1,068,881 | 869,815 | 1,059,082 | 866,346 | 393,112 | -54,189 | -808,860 | -1,370,099 | -2,000,534 | -1,972,089 | -1,989,410 | -1,250,714 | -1,118,335 | -768,718 | -730,142 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | 364,608 | 211,343 | |||||||||||||
Depreciation | 8,718 | 7,509 | 4,264 | 14,486 | 15,614 | 16,264 | 5,654 | 6,651 | 3,520 | 4,130 | 4,503 | 5,287 | 3,392 | 3,769 | 3,395 |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax | -91,240 | -40,669 | |||||||||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | -555,155 | 320,919 | 149,502 | 518,928 | 486,321 | -58,965 | -430,699 | -249,125 | -358,156 | 787,154 | -78,898 | 326,936 | 831,696 | 153,885 | 409,158 |
Creditors | 53,325 | -112,249 | 19,871 | 39,140 | 142,698 | 55,646 | -44,154 | 33,502 | -3,563,256 | -308,978 | 808,184 | 514,281 | 1,084,392 | 286,799 | 1,243,602 |
Accruals and Deferred Income | -655,981 | 356,519 | -128,648 | 266,906 | 384,485 | -1,689,030 | -801,146 | -637,822 | 3,450,958 | 1,013,135 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 36,071 | 1,218 | -651 | -2,445 | -1,003 | 4,149 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | 270,656 | 102,752 | |||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | -945,142 | 945,142 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||||||||||
interest | 698 | 59 | |||||||||||||
cash flow from financing | 698 | 59 | |||||||||||||
cash and cash equivalents | |||||||||||||||
cash | 191,938 | -276,420 | -61,930 | 271,606 | -451,865 | 104,813 | 148,124 | 281,365 | 208,666 | -61,546 | 147,435 | 54,068 | -94,529 | 96,612 | 95,537 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 191,938 | -276,420 | -61,930 | 271,606 | -451,865 | 104,813 | 148,124 | 281,365 | 208,666 | -61,546 | 147,435 | 54,068 | -94,529 | 96,612 | 95,537 |
expert publishing medicine ltd Credit Report and Business Information
Expert Publishing Medicine Ltd Competitor Analysis
Perform a competitor analysis for expert publishing medicine ltd by selecting its closest rivals, whether from the INFORMATION AND COMMUNICATION sector, other small companies, companies in SW1P area or any other competitors across 12 key performance metrics.
expert publishing medicine ltd Ownership
EXPERT PUBLISHING MEDICINE LTD group structure
Expert Publishing Medicine Ltd has no subsidiary companies.
Ultimate parent company
COMPUTERSHARE LTD
#0024414
2 parents
EXPERT PUBLISHING MEDICINE LTD
04059017
expert publishing medicine ltd directors
Expert Publishing Medicine Ltd currently has 3 directors. The longest serving directors include Mr Simon Bane (Nov 2023) and Mr Mark Dennis (Nov 2023).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Simon Bane | 53 years | Nov 2023 | - | Director | |
Mr Mark Dennis | United Kingdom | 50 years | Nov 2023 | - | Director |
Mr Nicholas Perkins | United Kingdom | 55 years | Nov 2023 | - | Director |
P&L
December 2023turnover
4.2m
-2%
operating profit
364.6k
+73%
gross margin
71.8%
-3.06%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
1.1m
+0.23%
total assets
2.9m
-0.11%
cash
653.9k
+0.42%
net assets
Total assets minus all liabilities
expert publishing medicine ltd company details
company number
04059017
Type
Private limited with Share Capital
industry
58141 - Publishing of learned journals
58190 - Other publishing activities
incorporation date
August 2000
age
25
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
future medicine limited (December 2023)
accountant
LEAPMAN WEISS
auditor
-
address
5 howick place, london, SW1P 1WG
Bank
-
Legal Advisor
-
expert publishing medicine ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to expert publishing medicine ltd. Currently there are 1 open charges and 0 have been satisfied in the past.
expert publishing medicine ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for EXPERT PUBLISHING MEDICINE LTD. This can take several minutes, an email will notify you when this has completed.
expert publishing medicine ltd Companies House Filings - See Documents
date | description | view/download |
---|